Immune reconstitution to Mycobacterium tuberculosis after discontinuing infliximab [1]

International Journal of Tuberculosis and Lung Disease

Volumn 9, Issue 9, 2005, Pages 1057-1058

  Belknap, Robert ^a   Reves, Randall ^b   Burman, William ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b Denver Public Health ^*  (United States)

Author keywords

Immune reconstitution; Infliximab; TNF ; Tuberculosis

Indexed keywords

CORTICOSTEROID; ETHAMBUTOL; INFLIXIMAB; ISONIAZID; METHOTREXATE; PREDNISONE; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

AGED; CASE REPORT; DISEASE COURSE; FEMALE; GERIATRIC PATIENT; HUMAN; IMMUNE RESPONSE; LETTER; LUNG DISEASE; MYCOBACTERIUM TUBERCULOSIS; PLEURA EFFUSION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULOSIS;

AGED; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27644581604     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Keane, J, Gershon, S, Wise, R P, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent, [see comment]. N Engl J Med 2001; 345: 1098-1104.
2. Centers for Disease Control and Prevention. Tuberculosis associated with tumor necrosis factor-alpha-California 2002-2003. Morb Mortal Wkly Rep 2004; 53: 683-686.
3. Breen, R, Smith, C, Bettinson, H, et al. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax 2004; 59: 704-707.
4. Taylor, J C, Orkin, R, Lanham, J. Tuberculosis following therapy with infliximab may be refractory to antibiotic therapy. Rheumatology (Oxford) 2003; 42: 901-902.
5. Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Morb Mortal Wkly Rep 1998; 47: 1-58.